Transplantation for Patients With Chronic Lymphocytic Leukemia
Trial ID or NCT#
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia
- - adequate organ function - normal bone marrow cytogenetics
- - active CNS disease - For autologous patients more than 30% bone marrow involvement
Contact us to find out if this trial is right for you.